Structure Database (LMSD)

Introduction | Text/ontology-based search | Structure-based search | Programmatic Access

LMSD: Lipid classification search results

Prenol Lipids [PR] (W) --> Isoprenoids [PR01]--> C25 isoprenoids (sesterterpenes) [PR0105]
LM_IDCommon NameSystematic NameFormulaMass
LMPR0105010001C25:3 6,7-Epoxy highly branched
isoprenoid
2,6,14-trimethyl-6,7-epoxy-10-
methylene-9-(3-methylpent-4-enyl)-
pentadec-2-ene
C25H44O360.3392
LMPR0105010002C25:2 6,7-Epoxy highly branched
isoprenoid
2,6,14-trimethyl-6,7-epoxy-10-
methylene-9-(3-methylpent-4-enyl)-
pentadecane
C25H46O362.3549
LMPR0105010003C25 6,7-Epoxy highly branched
isoprenoid
2,6,10,14-tetramethyl-6,7-epoxy-9-(3-
methyl-pentyl)-pentadecane
C25H50O366.3862
LMPR0105010004C25:4 Highly branched isoprenoid A2,6,10,14-tetramethyl-7-(3-methylene-
pent-4-enyl)-pentadeca-5E,9E-diene
C25H44344.3443
LMPR0105010005C25:4 Highly branched isoprenoid B2,6,10,14-tetramethyl-9E-(3-methyl-
pent-4-enylidene)-pentadeca-2,6Z-diene
C25H44344.3443
LMPR0105010006C25:4 Highly branched isoprenoid C2,6,10,14-tetramethyl-9E-(3-methyl-
pent-4-enylidene)-pentadeca-2,6E-diene
C25H44344.3443
LMPR0105010007C25:3 Highly branched isoprenoid A2,6,10,14-tetramethyl-9-(3-methylpent-
4-enyl)-pentadeca-2,10E-diene
C25H46346.3600
LMPR0105010008C25:3 Highly branched isoprenoid B2,6,10,14-tetramethyl-9E-(3-methylpent-
4-enylidene)-pentadec-6Z-ene
C25H46346.3600
LMPR0105010009C25:3 Highly branched isoprenoid C2,6,14-trimethyl-10-methylene-9-(3-
methylpent-4-enyl)-pentadec-6E-ene
C25H46346.3600
LMPR0105010010C25:3 Highly branched isoprenoid D2,6,10,14-tetramethyl-7-(3-methyl-pent-
4-enyl)-pentadeca-5E,9E-diene
C25H46346.3600
LMPR0105010011C25:2 Highly branched isoprenoid2,10,14-trimethyl-6-methylene-7-(3-
methyl-pent-4-enyl)-pentadecane
C25H48348.3756
LMPR0105010012C25:1 Highly branched isoprenoid2,6,10,14-tetramethyl-7-(3-methyl-pent-
4-enyl)-pentadecane
C25H50350.3913
LMPR0105010013C25 Highly branched isoprenoid2,6,10,14-tetramethyl-7-(3-methyl-
pentyl)-pentadecane
C25H52352.4069
LMPR0105010014all-trans-pentaprenyl diphosphate3,7,11,15,19-pentamethylicosa-2E,6E,
10E,14E,18-pentaen-1-yl trihydrogen
diphosphate
C25H44O7P2518.2562
LMPR0105020001Manoalide (W)-C25H36O5416.2563
LMPR0105020002C25:1 Monocyclic highly branched
isoprenoid
4-isopropyl-1-methyl-3-(2,6,10-
trimethyl-dodecan-6-yl)-cyclohex-1-ene
C25H48348.3756
LMPR0105020003C25:3 Monocyclic highly branched
isoprenoid
1-methyl-4-(prop-1-en-2-yl)-3-(2,6,10-
trimethyl-dodec-11-en-6-yl)-cyclohex-1-
ene
C25H44344.3443
LMPR0105020004C25 Monocyclic highly branched
isoprenoid
1-isopropyl-4-methyl-2-(2,6,10-
trimethyl-dodecan-6-yl)-cyclohexane
C25H50350.3913
LMPR0105030001(-)-Ceriferol 1-C25H40O356.3079
LMPR0105040001(+)-Dysideapalaunic acid-C25H40O2372.3028
LMPR0105040002(-)-Salvisyriacolide-C25H40O6436.2825
LMPR0105050001Ophiobolin A-C25H36O4400.2614
LMPR0105060001(+)-Scalarin(+)-12α,25α-dihydoxy-16-scalaren-24,25-
olide
C25H38O4402.2770
LMPR0105060002(+)-Desoxyscalarin(+)-24,25-epoxy-16-scalaren-12α,25α-
diol
C25H40O3388.2977
LMPR0105060003Hyrtial12β-hydroxy-25-nor-16-scalaren-24-alC24H38O2358.2872
LMPR010506000412-O-acetyl-16-O-deacetyl-16-epi-
scalarobutenolide
(4S,5aS,5bR,7aS,11aS,11bR,13R,13aR,
13bS)-4-hydroxy-5b,8,8,11a,13a-
pentamethyl-2-oxo-2,4,5,5a,5b,6,7,7a,8,
9,10,11,11a,11b,12,13,13a,13b-
octadecahydrochryseno[1,2-b]furan-13-
yl acetate
C27H40O5444.2876
LMPR010506000516-O-deacetyl-16-epi-scalarolbutenolide(4S,5aS,5bR,7aS,11aS,11bR,13R,13aR,
13bS)-4,13-dihydroxy-5b,8,8,11a,13a-
pentamethyl-5,5a,5b,6,7,7a,8,9,10,11,
11a,11b,12,13,13a,13b-
hexadecahydrochryseno[1,2-b]furan-2(4H)
-one
C25H38O4402.2770
 

logo LIPID MAPS is funded by a Wellcome Trust.